Xi-Lin Lu

Dr. Xi-Lin Lu


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2013 in Marine Drugs
Verified
Journal Article
Open access
PDF file
ZLZhen-Xing Li
Zhen-Xing Li
JCJian-Wen Chen
Jian-Wen Chen
YFYuan Feng
Yuan Feng
YHYun-Ying Huang
Yun-Ying Huang
LZLi-Yan Zhao
Li-Yan Zhao
YGYong-Yuan Guan
Yong-Yuan Guan
We previously reported that a novel marine compound, xyloketal B, has strong antioxidative actions in different models of cardiovascular diseases. Induction of heme oxygenase-1 (HO-1), an important endogenous antioxidant enzyme, has been considered as a potential therapeutic strategy for cardiovascular diseases. We here investigated whether xyloketal B exhibits its antioxidant activity through induction of HO-1. In human umbilical vein endothelial cells (HUVECs), xyloketal B significantly induced HO-1 gene expression and translocation of the nuclear factor-erythroid 2-related factor 2 (Nrf-2) in a concentration- and time-dependent manner. The protection of xyloketal B against angiotensin II-induced apoptosis and reactive oxygen species (ROS) production could be abrogated by the HO-1 specific inhibitor, tin protoporphyrin-IX (SnPP). Consistently, the suppressive effects of xyloketal B on NADPH oxidase activity could be reversed by SnPP in zebrafish embryos. In addition, xyloketal B induced Akt and Erk1/2 phosphorylation in a concentration- and time-dependent manner. Furthermore, PI3K inhibitor LY294002 and Erk1/2 inhibitor U0126 suppressed the induction of HO-1 and translocation of Nrf-2 by xyloketal B, whereas P38 inhibitor SB203580 did not. In conclusion, xyloketal B can induce HO-1 expression via PI3K/Akt/Nrf-2 pathways, and the induction of HO-1 is mainly responsible for the antioxidant and antiapoptotic actions of xyloketal B.

30 May 2014 in Marine Drugs
Verified
Journal Article
Open access
PDF file
SLSi-Mei Long
Si-Mei Long
FLFeng-Yin Liang
Feng-Yin Liang
QWQi Wu
Qi Wu
XLXi-Lin Lu
Xi-Lin Lu
XYXiaoli Yao
Xiaoli Yao
ZPZhong Pei
Zhong Pei
High-throughput behavior-based screen in zebrafish is a powerful approach for the discovery of novel neuroactive small molecules for treatment of nervous system diseases such as epilepsy. To identify neuroactive small molecules, we first screened 36 compounds (1–36) derived from marine natural products xyloketals and marine isoprenyl phenyl ether obtained from the mangrove fungus. Compound 1 demonstrated the most potent inhibition on the locomotor activity in larval zebrafish. Compounds 37–42 were further synthesized and their potential anti-epilepsy action was then examined in a PTZ-induced epilepsy model in zebrafish. Compound 1 and compounds 39, 40 and 41 could significantly attenuate PTZ-induced locomotor hyperactivity and elevation of c-fos mRNA in larval zebrafish. Compound 40 showed the most potent inhibitory action against PTZ-induced hyperactivity. The structure-activity analysis showed that the OH group at 12-position played a critical role and the substituents at the 13-position were well tolerated in the inhibitory activity of xyloketal derivatives. Thus, these derivatives may provide some novel drug candidates for the treatment of epilepsy.

29 April 2015 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
XLXi-Lin Lu
Xi-Lin Lu
YLYue-Hao Lin
Yue-Hao Lin
QWQi Wu
Qi Wu
FSFeng-Juan Su
Feng-Juan Su
CYCheng-Hui Ye
Cheng-Hui Ye
XYXiaoli Yao
Xiaoli Yao
Parkinson’s disease (PD) is the second most common neurodegenerative disease, affecting 2% of the population aged over 65 years old. Mitochondrial defects and oxidative stress actively participate in degeneration of dopaminergic (DA) neurons in PD. Paeonolum, a main component isolated from Moutan cortex, has potent antioxidant ability. Here, we have examined the effects of paeonolum against MPP+-induced neurotoxicity in zebrafish and PC12 cells. The overall viability and neurodegeneration of DA neurons was assessed in ETvmat2:green fluorescent protein (GFP) transgenic zebrafish, in which most monoaminergic neurons are labeled by GFP. Damage to PC12 cells was measured using a cell viability assay and assessment of nuclear morphology. Intracellular reactive oxygen species (ROS) and the level of total GSH were assessed. The mitochondrial cell death pathway including mitochondrial membrane potential, cytochrome C release and caspase-3 activity were also examined in PC12 cells. Paeonolum protected against MPP+-induced DA neurodegeneration and locomotor dysfunction in zebrafish in a concentration-dependent manner. Similar neuroprotection was replicated in the PC12 cellular model of MPP+ toxicity. Paeonolum attenuated MPP+-induced intracellular ROS accumulation and restored the level of total GSH in PC12 cells. Furthermore, paeonolum significantly inhibited the mitochondrial cell death pathway induced by MPP+. Collectively, the present study demonstrates that paeonolum protects zebrafish and PC12 cells against MPP+-induced neurotoxicity.

28 May 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XYXiao-Li Yao
Xiao-Li Yao
CYCheng-Hui Ye
Cheng-Hui Ye
QLQiang Liu
Qiang Liu
Jian-Bo WanJian-Bo Wan
Jian-Bo Wan
JZJun Zhen
Jun Zhen
XLXi-Lin Lu
Xi-Lin Lu
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder mainly affecting motor neurons. Mutations in superoxide dismutase-1 (SOD-1) account for about 20% of familial ALS patients. A robust supply of motoneurons carrying the mutated gene would help understand the causes of motoneuron death and develop new therapeutics for the disease. Here, we established induced pluripotent stem (iPS) cell lines from SOD1G93A mice and compared their potency in motoneuron generation with normal iPS cells and mouse embryonic stem cells (E14). Our results showed that iPS cells derived from SOD1G93A mice possessed the similar potency in neuronal differentiation to normal iPS cells and E14 cells and can be efficiently driven to motoneuron-like phenotype. These cells exhibited typical neuronal morphology, expressed key motoneuron markers, including ChAT and HB9, and generated repetitive trains of action potentials. Furthermore, these neurons highly expressed human SOD-1 and exhibited shorter neurites compared to controls. The present study provides evidence that ALS-iPS cells can be used as disease models in high-throughput screening and mechanistic studies due to their ability to efficiently differentiate into specific neuronal subtypes.

6 December 2008 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
ZLZheng-Shan Liu
Zheng-Shan Liu
YXYong-Feng Xu
Yong-Feng Xu
SFShan-Wei Feng
Shan-Wei Feng
YLYong Li
Yong Li
XYXiao-Li Yao
Xiao-Li Yao
CZCheng Zhang
Cheng Zhang

20 January 2026 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
YGYingfeng Ge
Yingfeng Ge
YFYi Fei
Yi Fei
CDChonglong Ding
Chonglong Ding
SYShuo Yang
Shuo Yang
YFYingying Fang
Yingying Fang
JZJinxin Zhang
Jinxin Zhang
Introduction: Amnestic mild cognitive impairment (aMCI), serving as a clinical precursor to Alzheimer's Disease (AD), assumes a pivotal role in the early stages of AD prevention. The longitudinal collection of data in aMCI is imperative for monitoring disease progression and guiding clinical interventions. Methods: Utilizing a prospective cohort design, we recruited aMCI individuals and conducted a one-year follow-up study. During this period, electroencephalogram (EEG) signals were systematically collected at regular intervals, resulting in four time points for each participant. Based on the follow-up outcomes, participants were stratified into progressive mild cognitive impairment (PMCI) and stable mild cognitive impairment (SMCI) groups. We extracted spectral, nonlinear, and functional connectivity features from the EEG data at three cross-sectional time points in the initial nine months and constructed longitudinal features between these cross-sectional assessments. The longitudinal features were fed into machine learning classifiers to predict one-year follow-up outcomes. Results: The dynamic trends of EEG features in SMCI and PMCI patients exhibited inconsistency. Utilizing the selected longitudinal features, the support vector machine (SVM) demonstrated the best prediction performance, achieving an accuracy of 94.92%, an area under the curve of 93.25%, a sensitivity of 90.20%, a specificity of 98.80%, a positive predictive value of 98.70%, and an F1-score of 93.65%. Discussion: By capturing trend information associated with disease progression, longitudinal EEG features contributed to enhancing prediction performance in machine learning models.